Sargent Bickham Lagudis’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$3.47K Buy
+50
New +$3.47K ﹤0.01% 846